Jane Street’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253K Buy
+37,084
New +$278K ﹤0.01% 9608
2025
Q4
Sell
-11,638
Closed -$151K 10967
2025
Q3
$151K Buy
+11,638
New +$137K ﹤0.01% 9879
2025
Q2
Sell
-1,019
Closed -$12.3K 9494
2025
Q1
$12.3K Buy
1,019
+249
+32% +$3.56K ﹤0.01% 9184
2024
Q4
$11.8K Sell
770
-3,903
-84% -$73.7K ﹤0.01% 9167
2024
Q3
$108K Sell
4,673
-8,267
-64% -$185K ﹤0.01% 8970
2024
Q2
$251K Buy
12,940
+9,278
+253% +$249K ﹤0.01% 8078
2024
Q1
$138K Buy
3,662
+2,224
+155% +$92K ﹤0.01% 8394
2023
Q4
$43.5K Buy
+1,438
New +$31.4K ﹤0.01% 8805
2023
Q2
Sell
-9,802
Closed -$903K 8588
2023
Q1
$903K Buy
9,802
+8,752
+834% +$1.1M ﹤0.01% 5189
2022
Q4
$150K Sell
1,050
-12,225
-92% -$3.05M ﹤0.01% 7858
2022
Q3
$3.02M Buy
+13,275
New +$3.37M ﹤0.01% 3445
2021
Q2
Sell
-1,138
Closed -$238K 9685
2021
Q1
$238K Buy
+1,138
New +$261K ﹤0.01% 8030
2020
Q3
Sell
-455
Closed -$110K 7067
2020
Q2
$110K Buy
+455
New +$89.4K ﹤0.01% 6676
2019
Q2
Sell
-154
Closed -$117K 5057
2019
Q1
$117K Buy
+154
New +$140K ﹤0.01% 4752

Other funds holding ACET

Jane Street's ACET Position: Q1 2026 in Review

Jane Street opened a new position in Adicet Bio (ACET) in Q1 2026: 37,084 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #9608 among its holdings. This is a return to the name: Jane Street previously reported a position in ACET as recently as Q3 2025.

Jane Street first reported a position in ACET in Q1 2019 and has held it in 14 quarters since. The position peaked at $3.02M in Q3 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Jane Street held 37,084 shares of Adicet Bio worth $253K as of Q1 2026.
  • Adicet Bio was a new Jane Street position in Q1 2026.
  • Adicet Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9608 holding.
  • Jane Street first reported a position in Adicet Bio in Q1 2019 and has held it in 14 quarters since.
  • Jane Street's Adicet Bio position peaked at $3.02M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.